Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 3—March 2022

Disseminated Histoplasmosis in Persons with HIV/AIDS, Southern Brazil, 2010–2019

Rossana Patricia Basso, Vanice Rodrigues Poester, Jéssica Louise Benelli, David A. Stevens, and Melissa Orzechowski XavierComments to Author 
Author affiliations: Programa de Pós Graduação em Ciências da Saúde, Universidade Federal do Rio Grande, Rio Grande, Brazil (R.P. Basso, V.R. Poester, J.L. Benelli, M.O. Xavier); Hospital Universitário Dr. Miguel Riet Corrêa Jr., vinculado à Empresa Brasileira de Serviços Hospitalares, Rio Grande (R.P. Basso, J.L. Benelli); California Institute for Medical Research, San Jose, California, USA (D.A. Stevens); Stanford University Medical School, Stanford, California, USA (D.A. Stevens)

Main Article

Table 2

Frequency of co-infections in 31 patients with disseminated histoplasmosis diagnosed in persons living with HIV/AIDS, University Hospital Dr. Miguel Riet Corrêa Jr., Rio Grande, Brazil, 2010–2019

Infectious disease Frequency, % (no./total no. participants)
Oral candidiasis 61 (19/31)
Confirmed tuberculosis 29 (9/31)
Neurotoxoplasmosis 29 (9/31)
Pneumocystosis 23 (7/31)
Herpetic encephalitis 3 (1/31)
Herpes zoster 3 (1/31)
Syphilis 3 (1/31)
Medullary cytomegalovirus 3 (1/31)
Mycobacterium avium infection 3 (1/31)
Herpes simplex infection 3 (1/31)
Hepatitis C 3 (1/31)

Main Article

Page created: January 27, 2022
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.